急騰。ローソン店舗への「ChargeSPOT」設置を拡大し、今後3年間で約8,000店舗にバッテリースタンドの追加設置を目指すと発表し、好材料視されている。同社は2018年10月から「ChargeSPOT」をローソンの店舗に設置開始し、2024年3月末時点では約2,800店舗に設置を行っている。同社では、8,000店舗への設置が新たに追加されることで、今後の中長期的なパートナーシップ構築を目標に、協力体制をさらに強化していくための施策も広げていくとしている。＜4068＞ Basis 1217 +37
Surge. It was announced after the end of trading on the 17th that a share buyback would be implemented. The total number of shares that can be acquired is 26,000 shares (1.39% of the total number of issued shares excluding treasury stock), the total acquisition price is limited to 30 million yen, and the acquisition period is from June 18th to December 18th. The purpose is to enable flexible capital policies in response to changes in the management environment by comprehensively considering financial and stock market conditions.
＜9338＞ INFORICH 4020 +335
Surging. Lawson announced that it plans to expand the installation of "ChargeSPOT" battery stands at stores and aims to add them to about 8,000 stores over the next three years, which is considered positive news. The company began installing "ChargeSPOT" at Lawson's stores in October 2018 and had installed them in about 2,800 stores as of the end of March 2024. The company said that with the addition of new installations at 8,000 stores, it will expand its measures to further strengthen its cooperative efforts and to achieve medium- to long-term partnership building as a goal.
＜6696＞ TRACE OP 685 +71
Temporary measures for margin trading with a commission guarantee rate of more than 50% (including cash of more than 20%) for new sales and purchases through margin trading announced by the Tokyo Stock Exchange after the market closed on the 17th and set to be lifted from the 18th trading session. It is speculated that the burden of commission guarantees will be reduced and inflow of short-term funds will be revitalized, leading to buying.
＜9214＞ Recovery 1493 +78
Significantly surged. It announced a share buyback after the end of trading on the 17th. The total number of shares that can be acquired is 70,000 shares (4.95% of the total number of issued shares excluding treasury shares) with a total acquisition price limit of 100 million yen. The acquisition period is from July 1st to November 30th. Its purpose is to improve capital efficiency, enhance shareholder benefits, and enable flexible capital policy in the future.
＜4572＞ Karnabio 404 +24
A sharp rise. It is viewed as a positive development that it has presented promising initial data for the Phase 1b clinical trial targeting mature B-cell tumors of the next-generation BTK inhibitor AS-1763 at the European Hematology Association in 2024. Regarding the ongoing Phase 1b trial of AS-1763, promising initial data including tumor reduction effects for mature B-cell tumor patients with many previous treatments were announced in addition to good safety and pharmacokinetic profile results of AS-1763. It is planned to start a dose expansion part based on these promising data within 2024.
＜4167＞ Kokoperi 471 +43
Sharp rise. It is well received that it has announced the development of "BIG ADVANCE GLOBAL" after the end of trading on the 17th. The current mainstay of small and medium-sized enterprise (SME) DX support platform "Big Advance" is a business matching in Japan only, but it will be able to match with foreign companies. As part of its SME management support, it aims to support SMEs' overseas expansion by connecting Japanese SMEs with overseas companies through partnerships with local financial institutions overseas, despite the difficulty of overseas expansion despite the strong desire of many Japanese SMEs.